cyproterone 50mg tablets
medihealth (northern) ltd - cyproterone acetate - oral tablet - 50mg
cyprostat 50mg tablets
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - cyproterone acetate - tablet - cyproterone acetate 50 mg - sex hormones and modulators of the genital system
androcur tab 10 mg
شركة مستودع الأدوية الأردني - the jordan drugstore co - cyproterone acetate 10 mg - 10 mg
cyproterone generis 50 mg tablets
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - tablet - cyproterone acetate 50 mg - sex hormones and modulators of the genital system
procur
douglas pharmaceuticals limited - cyproterone acetate 100mg; ; - tablet - 100 mg - active: cyproterone acetate 100mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose povidone - in men · antiandrogen treatment in inoperable carcinoma of the prostate
procur
douglas pharmaceuticals limited - cyproterone acetate 50mg - tablet - 50 mg - active: cyproterone acetate 50mg excipient: lactose monohydrate magnesium stearate maize starch sodium starch glycolate starch
procur
douglas pharmaceuticals limited - cyproterone acetate 50mg; ; - tablet - 50 mg - active: cyproterone acetate 50mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose povidone - in men · antiandrogen treatment in inoperable carcinoma of the prostate
siterone
rex medical ltd - cyproterone acetate 100mg; ; ; - tablet - 100 mg - active: cyproterone acetate 100mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone pregelatinised maize starch
siterone
rex medical ltd - cyproterone acetate 50mg; ; ; - tablet - 50 mg - active: cyproterone acetate 50mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate povidone starch
cyrotone-100 cyproterone acetate 100mg tablet bottle
strides pharma science pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate - inoperable prostatic carcinoma. to suppress flare with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.